• Loading...

    DSHS HIV/STD Program

    Post Office Box 149347, MC 1873
    Austin, Texas 78714

    Phone: (512) 533-3000

    E-mail the HIV/STD Program

    E-mail data requests to HIV/STD Program - This email can be used to request data and statistics on HIV, TB, and STDs in Texas. It cannot be used to get treatment or infection history for individuals, or to request information on programs and services. Please do not include any personal, identifying health information in your email such as HIV status, Date of Birth, Social Security Number, etc.

    For treatment/testing history, please contact your local Health Department.

    For information on HIV testing and services available to Persons Living with HIV and AIDS, please contact your local HIV services organization.

Texas HIV-STD Clinical Conference Proceedings

Loading...

Clinical Session 1

Clinical Management of the HIV-Infected Client
Sharilyn K. Stanley, M.D., Chief, TDH Bureau of HIV and STD Prevention
Thursday, April 8, 1999, 8:30 - 10:00 a.m., Pine Room

Objectives

By the end of this session, participants will be able to:

  • recognize the essential components of a history and physical for the client with HIV disease;
  • determine the appropriate laboratory tests to be performed, including viral load and other diagnostic procedures;
  • recognize indications for the initiation of prophylactic regimens and opportunistic conditions;
  • describe indications for the initiation of antiretroviral therapy in both asymptomatic and symptomatic clients; and
  • list current choices for antiretroviral therapy.

Sharilyn K. Stanley, M.D.
Chief, Bureau of HIV and STD Prevention
Texas Department of Health
Austin, Texas
Dr. Stanley attended medical school at Baylor College of Medicine and completed her residency at the University of Arkansas for Medical Science, Little Rock, Arkansas. After completing a fellowship under Dr. Anthony Fauci in Allergy and Immunology at the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Dr. Stanley continued as a Principle Investigator in the Laboratory of Immunoregulation under Dr. Fauci, investigating the immunopathogenesis of HIV infection. She was responsible for demonstrating the impact of stressers such as heat shock and ultraviolet irradiation of HIV expression, and was the first to prove convincingly the in vivo infection of bone marrow progenitor cells with HIV. She delineated the pathogenesis of HIV infection of the thymus, using the Scid-hu mouse model, and demonstrated the massive destruction of thymic stroma and infection of stromal epithelial cells; this thymic estruction is now felt to be a significant contributor to the failure of regeneration of the immune system after infection with HIV. Dr. Stanley also showed the impact of tetanus vaccination of HIV-infected patients: the transient expression of HIV in response to vaccination, associated with evidence of in vivo immune stimulation, was direct in vivo proof of our understanding, derived from in vitro laboratory experiments, of the role of immune activation in progression of HIV disease. Dr. Stanley moved from the Laboratory to Special Advisor to the Director, National Institute of Allergy and Infectious Diseases, where she coordinated the HIV/AIDS and TB programs of the Institute and represented the Institute on multiple HHS agency panels and functions. In this capacity, she served as Executive Secretary to the HHS/Kaiser Panel on Clinical Practices for HIV Infection, and was the responsible author for the HHS Guidelines for the Use of antiretroviral Therapy in HIV Infection, published in 1998. She continues to pursue her interests in HIV disease and public health in her current position as Chief of the Bureau of HIV and STD Prevention within the Texas Department of Health.

Clinical Session 2

Prevention of Perinatal Transmission of HIV Disease
Celine Hanson, M.D., Allergy/Immunology Section, Texas Children's Hospital
Thursday, April 8, 1999, 10:30 - 11:30 a.m., Pine Room

Objectives

By the end of this session, participants will be able to:

  • review Current U.S. Public Health Service guidelines for antiretroviral therapy to interrupt perinatal HIV transmission; and
  • provide an overview of current prophylactic Perinatal Clinical Trials (ACTG #358 and #316).

Celine Hanson, M.D.
Texas Children's Hospital
Allergy/Immunology Section
Houston, Texas
Dr. Hanson received her medical education at Southwestern Medical School in Dallas. She completed her postgraduate education in pediatrics and allergy/immunology at Baylor College of Medicine, and epidemiology at Emory University School of Public Health in Atlanta. She currently holds an academic appointment as Associate Professor of Pediatrics, Baylor College of Medicine in allergy/immunology and is Board Certified in pediatrics and allergy/immunology. Dr. Hanson is a principal investigator on several current research projects, including the National Institute of Allergy and Infectious Diseases "Women and Infants Transmission Study (WITS II) and the NIAIDS "Pediatric AIDS Clinical Trial Group." She is a committee member for the Allergy and Immunology Section Executive Committee of the American Academy of Pediatrics, and a member of the Scientific Advisory Committee for the Pediatric AIDS Foundation. She is a member of numerous professional societies, and the author of many professional articles, including "Molecular drug resistance and the risk of maternal-infant transmission in the women and infants transmission study," submitted to the Journal of Infectious Disease last year. Dr. Hanson also has served on many voluntary boards and committees.

Clinical Session 3

Epidemiology of HIV in the U.S. and Texas; HIV Named Reporting
Sharon Melville, MD, Director, Epidemiology Division, TDH Bureau of HIV and STD Prevention
Thursday, April 8, 1999, 11:30 - 12:00 p.m., Pine Room

Objectives:

By the end of this session, participants will be able to:

  • outline the trends in HIV infection and AIDS in Texas and compare these to national trends;
  • describe changes in the populations at risk for contracting HIV infection;
  • discuss the epidemiology of HIV infection and AIDS for pediatric and adolescent age groups in Texas; and
  • describe recent changes in requirements of the Texas Board of Health for HIV named reporting.

Sharon K. Melville, M.D., M.P.H.
Director, HIV/STD Epidemiology Division
Texas Department of Health
Austin, Texas
Dr. Melville has been associated with preventive medicine research activities since 1991 when she became a Preventive Medicine Research Fellow at the University of Massachusetts Medical Center. In 1993, she was appointed an Assistant Professor of Preventive Medicine at the University of Massachusetts Medical Center. Since 1996, she has served as the Director to the HIV/STD Epidemiology Division, Texas Department of Health, and the Principal Investigator for the HIV research activities of the Texas Department of Health. She is the author of seven professional articles and five abstracts. She serves on several scientific and public health associated committees and action groups.

Clinical Lunch Session

Energizing For Change
Margo Long, Director, Center for Gifted Education, Whitworth College
Friday, April 9, 1999, 10:00 - 12:00 p.m., Ballrooms B/C

Goal

The overall goal of this presentation is to provide participants with an overview of current management theory and the skills necessary to carry out this approach.

Objectives

By the end of this session, participants will be able to:

  • describe current challenges in constant change;
  • identify current management theories; and
  • define skills appropriate to effectively manage in today's world of change.

Margo Long
Director
Center for Gifted Education
Whitworth College
Spokane, Washington
Margo Long, Founder and Director of the Center for Gifted Education, is an Associate Professor of Education and Supervisor of secondary level education students for the School of Education at Whitworth College. She specializes in teaching creative problem-solving, communication, learning styles and gifted education. As a consultant in the Pacific Northwest, Margo actively serves health and teaching professions, as well as the business sector. Her provocative and enthusiastic presentation style is challenging, as well as practical for participants.

Clinical Session 4

Tuberculosis (TB) Issues in the Community: A Panel Presentation
Mary Bittle, M.A., R.N.C., Clinical Instructor, Division of Nursing, Stephen F. Austin State University
Wilbert Brown, Ed. D., Executive Director, Health Horizons of East Texas
Wendy Duggleby, M.N., R.N., A.O.C.N., Instructor, Division of Nursing, Stephen F. Austin State University
Sharon Flournoy, M.S.N., R.N., Director of Nursing, TDH Public Health Regions 4/5 North
Celia Robinson, M.S.N., R.N., TB Elimination Program Manager, TDH Public Health Regions 4/5 North
Thursday, April 8, 1999, 1:30 - 3:00 p.m., Pine Room

Objectives:

By the end of this session, participants will be able to:

  • describe collaborative efforts between multiple health care agencies and BSN students to provide tuberculosis screening
  • to a high-risk population in the community setting; and
  • identify potential applications of a collaborative service delivery model for delivering preventive health service to HIV-infected populations.

Mary Bittle, M.A., R.N.C.
Clinical Instructor Division of Nursing
Stephen F. Austin State University
Nacogdoches, Texas
Mary Bittle is a Clinical Instructor in the Nursing Division at Stephen F. Austin State University in Tyler, Texas.

Wilbert Brown, Ed. D.
Executive Director
Health Horizons of East Texas, Inc.
Nacogdoches, Texas
Wilbert Brown is the Executive Director of Health Horizons of East Texas, Inc., a community-based non-profit HIV/AIDS service organization located in Nacogdoches, Texas.

Wendy Duggleby, M.N., R.N., A.O.C.N.
Instructor, Division of Nursing
Stephen F. Austin State University
Nacogdoches, Texas
Wendy Duggleby is an Instructor in the Nursing Division at Stephen F. Austin State University in Tyler, Texas.

Sharon Flournoy, M.S.N., R.N.
Region Director of Nursing
Public Health Region 4 & 5 North
Texas Department of Health
Tyler, Texas
Sharon Flournoy is the Regional Director for Nursing in Public Health Regions 4 and 5 North for the Texas Department of Health in Tyler, Texas.

Celia Robinson, M.S.N., R.N.
Tuberculosis Elimination Program Manager
Public Health Region 4 & 5 North
Texas Department of Health
Tyler, Texas
Celia Robinson is the Tuberculosis Program Manager for Public Health Regions 4 and 5 North for the Texas Department of Health in Tyler, Texas.

Clinical Session 5

Integrating STDs Screening Into HIV Treatment
Dianne Blocker, R.N.C., W.H.C.N.P., STD/HIV Clinic Supervisor, Dallas County HHS
Thursday, April 8, 1999, 3:30 - 4:30 p.m., Pine Room

Objectives

By the end of this session, participants will be able to:

  • describe current trends in HIV and other STDs;
  • identify the need for STD screening based upon client's sexual history;
  • understand the relationship between ulcerative STD disease and the risk of HIV infection;
  • recognize the link between treatment of STD and prevention of HIV; and
  • identify local referral resource(s) for STD screening in the community.

Dianne Blocker, R.N.C., W.H.C.N.P.
STD/HIV Clinic Supervisor
Dallas County Health and Human Services
Dallas, Texas
Dianne Blocker completed the Women's Health Care Nurse Practitioner program at Southwestern Medical School in 1996. She is currently the STD/HIV Clinic Supervisor at Dallas County Health and Human Services in Dallas, Texas. Ms Blocker has extensive clinical experience in providing health services to people with sexually transmitted diseases and has served on an expert review panel for the development of STD Clinical Practice Guidelines.

Conference Home


Last updated March 10, 2011